Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases Academic Article uri icon

Overview

MeSH Major

  • Brachytherapy
  • Brain Neoplasms
  • Cesium Radioisotopes
  • Intraoperative Care
  • Neurosurgical Procedures

abstract

  • The use of postresection permanent (131)Cs brachytherapy implants resulted in no local recurrences and no radiation necrosis. This treatment was safe, well tolerated, and convenient for patients, resulting in a short radiation treatment course, high response rate, and minimal toxicity. These findings merit further study with a multicenter trial.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4249933

Digital Object Identifier (DOI)

  • 10.3171/2014.3.JNS131140

PubMed ID

  • 24785322

Additional Document Info

start page

  • 338

end page

  • 48

volume

  • 121

number

  • 2